Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: A placebo-controlled, randomized, double-blind, parallel-group study

Menopause

Volumn 21, Issue 4, 2014, Pages 361-368

  Anttalainen, Ulla ^a,b   Saaresranta, Tarja ^a,b   Vahlberg, Tero ^c   Polo, Olli ^b,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Department of Biostatistics Turku University ^*  (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Medroxyprogesterone acetate; Postmenopausal women; Sleep disordered breathing

Indexed keywords

AMITRIPTYLINE; CARBON DIOXIDE; CITALOPRAM; FLUOXETINE; MEDROXYPROGESTERONE ACETATE; PLACEBO; OXYGEN;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LABORATORY TEST; OXYGEN SATURATION; PARALLEL DESIGN; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDERED BREATHING; SLEEP STAGE; BLOOD; DRUG EFFECTS; MIDDLE AGED; SLEEP; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

CARBON DIOXIDE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; OXYGEN; PLACEBOS; POSTMENOPAUSE; SLEEP; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 84897559905     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000130     Document Type: Article

References (42)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas 2011;68:224-232.
3. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 2001;163:608-613.
4. Saaresranta T, Polo O. Sleep-disordered breathing and hormones. Eur Respir J 2003;22:161-172.
5. Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120:1448-1454.
6. Skatrud JB, Dempsey JA, Kaiser DG. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J Appl Physiol 1978;44:939-944.
7. Zwillich CW, Natalino MR, Sutton FD, Weil JV. Effects of progesterone on chemosensitivity in normal men. J Lab Clin Med 1978;92:262-269.
8. Driver HS, McLean H, Kumar DV, Farr N, Day AG, Fitzpatrick MF. The influence of the menstrual cycle on upper airway resistance and breathing during sleep. Sleep 2005;28:449-456.
9. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 2009; 89:134-152.
10. Anttalainen U, Saaresranta T, Kalleinen N, Aittokallio J, Vahlberg T, Polo O. CPAP adherence and partial upper airway obstruction during sleep. Sleep Breath 2007;11:171-176.
11. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002;121:430-435.
12. Petri N, Svanholt P, Solow B, WildschiLdtz G, Winkel P. Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo-controlled trial using parallel group design. J Sleep Res 2008;17:221-229.
13. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005;19:CD001004.
14. Saaresranta T, Polo-Kantola P, Rauhala E, Polo O. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Eur Respir J 2001;18:989-995.
15. Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab 2011;96:E614-E623.
16. Kryger M, McCullough R, Collins D, Scoggin C, Weil J, Grover R. Treatment of excessive polycythemia of high altitude with respiratory stimulant drugs. Am Rev Respir Dis 1978;117:455-464.
17. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects. Los Angeles, CA: Brain Information Service/Brain Research Institute, UCLA, 1968.
18. Bonnet M, Carley D, Carskadon M, et al; The Atlas Task Force. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-184.
19. Shahar E, Redline S, Young T, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003;167: 1186-1192.
20. Block AJ, Wynne JW, Boysen PG, Lindsey S, Martin C, Cantor B. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981;70:506-510.
21. Collop NA. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest 1994;106:792-799.
22. Pickett CK, Regensteiner JG, Woodard WD, Hagerman DD, Weil JV, Moore LG. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989;66:1656-1661.
23. Hachul H, Bittencourt LR, Andersen ML, Haidar MA, Baracat EC, Tufik S. Effect of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet 2008;103: 207-212.
24. Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesteroneinduced changes in sleep in male subjects. Am J Physiol 1997;272: E885-E891.
25. Schüssler P, Kluge M, Yassouridis A, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2008;33:1124-1131.
26. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003;26:163-168.
27. Cistulli PA, Barnes DJ, Grunstein RR, Sullivan CE. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702.
28. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999;6:196-200.
29. Kimura H, Tatsumi K, Kunitomo F, et al. Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading. Am Rev Respir Dis 1989;139:1198-1206.
30. Lyons HA, Huang CT. Therapeutic use of progesterone in alveolar hypoventilation associated with obesity. Am J Med 1968;44:881-888.
31. Rajagopal KR, Abbrecht PH, Jabbari B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986;90:815-821.
32. Strohl KP, Hensley MJ, Saunders NA, Scharf SM, Brown R, Ingram RH Jr. Progesterone administration and progressive sleep apneas. JAMA 1981;245:1230-1232.
33. Africander D, Verhoog N, Hapgood JP. Molecular mechanisms of steroid receptorYmediated actions by synthetic progestins used in HRT and contraception. Steroids 2011;76:636-652.
34. Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause 2001;8:10-16.
35. Tapanainen J, Kauppila A, Metsä-Ketelä T, Vapaatalo H. Prostanoids and catecholamines after oral administration of natural progesterone. Gynecol Endocrinol 1989;3:135-142.
36. Freeman EW, Purdy RH, Coutifaris C, Rickels K, Paul SM. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 1993;58:478-484.
37. Söderpalm AH, Lindsey S, Purdy RH, Hauger R, Wit de H. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 2004;29:339-354.
38. Hachul H, Andersen ML, Bittencourt LR, Santos-Silva R, Conway SG, Tufik S. Does the reproductive cycle influence sleep patterns in women with sleep complaints? Climacteric 2010;13:594-603.
39. Sahlin C, Franklin KA, Stenlund H, Lindberg E. Sleep in women: normal values for sleep stages and position and the effect of age, obesity, sleep apnea, smoking, alcohol and hypertension. Sleep Med 2009;10:1025-1030.
40. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006;29:1009-1014.
41. Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med 2004;164:406-418.
42. Koren D, Levitt Katz LE, Brar PC, Gallagher PR, Berkowitz RI, Brooks LJ. Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care 2011;34:2442-2447.